Search

everythinglearnresearchcommunity

for

Search:↓

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

Oral baricitinib is effective and safe for treating alopecia areata.

Oxymetazoline cream 1.0% effectively reduces rosacea redness, and using baseline photos improves assessment accuracy.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

The treatment was effective and tolerable for advanced gastric cancer.

Low-dose dutasteride effectively and safely promotes hair growth in men.

The treatment increased hair follicle counts and is potentially effective for male hair loss without serious side effects.

The treatment showed promising hair regrowth in advanced-stage hair loss.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Cromolyn sodium's effectiveness for treating asthma in children under 2 is unclear, possibly more beneficial for older children, and further research is needed.

A new method uses expert reviews of home videos to objectively assess children's developmental milestones in single-arm trials.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

The treatment was not recommended due to limited effectiveness and significant side effects.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Using a special laser and skin medication together successfully cleared a skin condition in a pregnant woman.